Aprameya Engineering installs, sets up, and maintains Intensive Care Units, Neonatal Intensive Care Units, Pediatric Intensive Care Units, Operation Theaters, and prefabricated structure wards in hospitals and medical care facilities on a turnkey basis. They also supply high-end medical equipment and diagnostic tools to private hospitals, public hospitals, and healthcare professionals. Aprameya Engineering IPO will hit the stock market in January 2023.
Table of Contents
About Aprameya Engineering
They have evolved and developed their capabilities in offering end-to-end solutions in the field of healthcare services relating to ICU setup, operation theatre setup, and providing medical equipment for streamlining operations related to patient treatment, monitoring, and diagnosis by hospitals, physicians’ offices, and other healthcare facilities over the years on the basis of their knowledge and understanding of the requirements of medical practitioners, industry standards, and the utility of the medical equipment.
On September 5, 2003, they established their partnership firm and throughout the years have expanded it with the aim of providing healthcare solutions that are more affordable and easily accessible.
They have shown strong financial performance, an increase in operating revenue, restated profit for the year, & better margins.
Business
Aprameya Engineering Limited has expanded their business activity by offering turnkey healthcare infrastructure solutions by setting-up ICU, NICU, PICU, operation theater projects, and prefabricated structure ward on a turnkey basis in 2020.
This is due to their knowledge, experience, and expertise of over one and a half decades in delivering medical devices for patient care at reasonable outlay.
Designing and installing modular and prefabricated operating theaters and intensive care units, operating rooms and intensive care pendants, LED operating lights and OT tables, high-care hospital beds, setting up medical gas pipeline solutions, high-value equipment like ventilators, multipara patient monitoring systems, critical care equipment, diagnostic equipment, CSSD equipment, and establishing mini laboratories are all part of Aprameya Engineering’s medical and healthcare infrastructure solutions.
Products
The range of goods and services offered by Aprameya Engineering Limited can be divided into two groups: dealing in high-end medical equipment and establishing healthcare infrastructure within hospitals and healthcare facilities.
They supply hospitals, doctors, and diagnostic service providers with need-based medical equipment such patient monitoring systems, cardiology devices, respiratory management systems, and radiology/imaging systems.
Harmonic ultrasonic surgical tools, patient monitoring systems, ventilators, ventilators (NIV), ABG machines, integrated electro-surgical units, & anesthetic delivery systems are just a few of the key critical care goods they provide.
Through timely and cost-effective supply of medical equipment, Aprameya Engineering has over the years managed to preserve positive relationships with their clients. These relationships with clients has enabled them to create a wide customer base.
Aprameya Engineering IPO
Aprameya Engineering Limited, headquartered in Visakhapatnam has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of 50,00,000 Equity Shares on 07 September 2022.
The offer includes a fresh issue of 50,00,000 Equity Shares and there is no offer for sale (OFS) by the promoters mentioned in the DRHP. They are not looking for any Pre-IPO placement in this issue.
-
- Initial Public Offering
They are now waiting for approval from Securities and Exchange Board of India(SEBI) to float the initial public offering (IPO) in the market.
Financials Trends
| Particulars | For the year/period ended ( in Cr.) | ||||
|---|---|---|---|---|---|
| 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |||
| Total Assets | 48.74 | 10.91 | 13.98 | ||
| Total Revenue | 200.26 | 26.01 | 12.33 | ||
| Profit After Tax | 16.61 | 0.86 | 0.65 | ||
Basic and Diluted Earnings Per Share
| Financial Period | Basic EPS (in INR) | Diluted EPS (in INR) | Weight |
| Financial Year 2020 | 0.47 | 0.47 | 3 |
| Financial Year 2021 | 0.61 | 0.61 | 2 |
| Financial Year 2022 | 11.86 | 11.86 | 1 |
| Weighted Average | 6.22 | 6.22 | |
Objects of the Issue
- Prepayment / repayment of all or a portion of the outstanding borrowings of the company to be availed on consolidated basis.
- To meet common corporate objectives.
Basis of the offer
Aprameya Engineering Limited feel that the following qualitative factors & business strengths enable them to compete successfully in the industry, and that these factors will be used to calculate the Offer Price:
- Business expansion at a rapid pace with an emphasis on building out the infrastructure for healthcare.
- History of success in establishing up ICUs, NICUs, PICUs, and Operation Theaters.
- Firm agreements with numerous manufacturers and suppliers of medical equipment.
- A large customer base that includes several private and public hospitals and medical schools.
- Promoters with technical team experience and domain expertise
- Scalable company model with little assets.
Aprameya Engineering Peer Comparison
There are no listed companies in India that run a comparable type of business to theirs. As a result, it is impossible to compare their company to others in its field.
Aprameya Engineering IPO Details
| IPO Opening Date | January 2023 |
| IPO Closing Date | January 2023 |
| Issue Type | Book Building |
| Face Value | 10 per share |
| IPO Price | 0 to 0 per equity share |
| Market Lot | – |
| Min Amount | – |
| Listing At | BSE, NSE |
| Issue Size | 50,00,000 Equity Shares |
| Fresh Issue | 50,00,000 Equity Shares |
| Offer for Sale | 0 |
Aprameya Engineering IPO Date
Aprameya Engineering Limited IPO opening date is January 2023, and the closing date is January 2023. The Aprameya Engineering issue may list in January 2023.
| IPO Opening Date | January 2023 |
| IPO Closing Date | January 2023 |
| Basis of Allotment Date | January 2023 |
| Initiation of Refunds | January 2023 |
| Credit of Shares to Demat Account | January 2023 |
| IPO Listing Date | January 2023 |
Basis of Allotment
| Type | % of Offer | Basis of Allotment |
|---|---|---|
| Qualified Institutional Buyer | 75 |
Roughly equivalent
|
| Non Institutional Investor | 15 |
Roughly equivalent
|
| Retail | 10 | Minimum 1 lot based on availability |
Aprameya Engineering IPO Status
Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.
Here, you can find the Allotment Status of Aprameya Engineering IPO.
Aprameya Engineering IPO GMP
Aprameya Engineering Limited IPO Grey Market Premium is 0. You can check out GMP of Other IPOs on below Links:
| Date | GMP (in Rs) | Subject to Sauda | Kostak (in Rs) |
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 | |||
| January 2023 |
Check Out the GMP of all Other IPOs
Aprameya Engineering Limited IPO Review
Aprameya Engineering Limited IPO review will depend on the price band which will be announced after SEBI approval. Whenever it will be announced we will update you regarding review of Aprameya Engineering IPO is good or bad.
Aprameya Engineering Limited IPO Risk
- Their business & financial performance may be significantly and negatively impacted by the loss of any of their important clients or a major drop in demand from these clients.
- They rely on Indian state governments for a portion of their business, which is primarily awarded through open bidding procedures.
- Their Order Book might not accurately predict their future performance, & their actual revenue might be far lower than the projections made in their Order Book, which would have a negative impact on their operational results.
- Their recent diversification into the installation, setup, & maintenance of ICU, NICU, PICU, & operation theaters exposes them to risks connected with new products & raises the possibility that they won’t be able to successfully implement their new business models.
Other Threats
- They run the danger of purchasing medical supplies from unreliable sources. Such third parties’ inability to fulfill their responsibilities could have a negative impact on their operations and business.
- They run the danger of purchasing medical supplies from unreliable sources. The cash flows, financial status, and operational performance of their business could all suffer if such third parties fail to fulfill their promises.
- Any delays in the completion of their ongoing and upcoming projects could result in the cancellation of work orders or cost overruns, which would be detrimental to their cash flow, operations, financial condition, and results of operations.
- Their promoters, directors, and other parties are leasing some of their properties, including the Registered Office, Branch Office, and Warehouse.
Projects
Since fisal year 2020 they have installed approximately 1181 critical care beds, including ICUs, NICUs, PICUs, & modular operating rooms, costing more than 12,000 Lakhs throughout the state of Rajasthan.
For many government hospitals, including Dr. S N Medical College in Jodhpur, Government Medical College in Kota, RMSCL in Jaipur, RNT Medical College in Udaipur, & SMS Medical College in Jaipur, these healthcare infrastructure projects have been done.
Government Medical College & Hospital Dungarpur, RNT Medical College & Controller, SMS Medical College, Jaipur, Government Medical College & Controller A.G. of Hospital, Kota, Government Medical College, Pali, Barmer, Jhalawar & DR. S N Medical College, Jodhpur, and MGH Hospital are just a few of the 11 projects they are currently working on for various government & private hospitals.
Aprameya Engineering Limited IPO Brokerage views
Once the dates will be announced we will update the views of different brokerage firms regarding this IPO. Here is the views of different stock brokers regarding this Aprameya Engineering IPO:
- Yes Securities : Not Updated
- Choice Brokering: Not Updated
- Axis Securities: Not Updated
- IIFL Securities: Not Updated
- Trade swift: Not Updated
- Anand Rathi : Not Updated
- ICICI Securities: Not Updated
Aprameya Engineering Limited IPO Subscription Status
| Date | Day | QIB | NII | Retail | Employees | Total Subscription |
| January 2023 | 1 | |||||
| January 2023 | 2 | |||||
| January 2023 | 3 |
Aprameya Engineering Limited Management
They are guided by their seasoned Promoters Saurabh Kishorbhai Bhatt & Chetan Mohan Joshi, who are assisted by their group of seasoned senior management, engineers, and other staff members.
Their promoters, Saurabh Kishorbhai Bhatt & Chetan Mohan Joshi, have over 18 years of experience in the business of dealing with expensive medical equipment.
They have benefited from the solid understanding of the marketing, technical specifications, and utility of high-end medical equipment, as well as from their Promoters’ experience and good knowledge of industry standards that are relevant to the medical sector.
They have developed from a tiny firm into a successful business engaged in supplying medical equipment to the demands of the healthcare sector under the direction and leadership of their Promoters.
Aprameya Engineering Limited‘ Promoters
- Saurabh Kishorbhai Bhatt
- Chetan Mohan Joshi
Principal Shareholder’s Holding
| Pre Issue Share Holding | 98.57% |
| Post Issue Share Holding |
Aprameya Engineering Limited Prospectus
Contact Details
Aprameya Engineering Limited
908, 9th Floor, Venus Atlantis Corporate Park,
Anandnagar, Prahladnagar, Ahmedabad,
Gujarat-380015 India
Tel: + (91) 79-40068827
E-mail: [email protected]
Website: www.aelhealth.com
Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park,
L.B.S. Marg, Vikhroli (West),
Mumbai 400 083, Maharashtra, India
Telephone: +91 (22) 4918 6200
E-mail : [email protected]
Website: www.linkintime.co.in
Lead Manager(s)
- Hem Securities Limited
We hope we are able to answer all your questions about Aprameya Engineering IPO. If you don’t have a Demat account, open it now with Zerodha best trading app of India.
Disclaimer
The reference of IPO Grey Market Premium (IPO GMP) is only valid for the date specified in the header.
On the IPO Grey Market, we do not purchase or sell IPO forms.
The Kostak Rate is the profit earned by selling an IPO application (in an off-market transaction) to somebody else before the issue is allotted or listed.
Do not subscribe to an IPO based solely on the premium price, as it may alter at any time before to the listing. Only consider the fundamentals of the companies when subscribing.
The GMP rates for IPOs are based on market intelligence. Please keep in mind that these IPO GMP rates may vary by geography and market.
Note:
Profit must do not engage in grey market trading or facilitate the purchase or sale of IPO forms. We don’t endorse such activities at all. We are sticky against such activities & never advise anyone to trade in grey market at all.
FAQ
Aprameya Engineering Limited IPO Opening Date?
Aprameya Engineering Limited IPO will open in January 2023.
Aprameya Engineering Limited IPO Listing Date?
Aprameya Engineering Limited IPO will list in January 2023.
Aprameya Engineering IPO GMP Today?
Aprameya Engineering IPO Grey Market Premium is INR 0 .
Aprameya Engineering Limited IPO Allotment Date?
Aprameya Engineering Limited IPO basis of allotment will be in January 2023.
Lot size for Aprameya Engineering Limited IPO?
Lot size for Aprameya Engineering Limited IPO is 0.
